Williams Timothy

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return2%(2%)< 1%1%0%
Sale Success Rate3 of 40 of 42 of 41 of 40 of 4

Vanda Pharmaceuticals, Inc.

Drugs » Biotechnology

SVP & General Counsel:

Holdings: 196.82K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--